Engaging patient advocacy groups can provide access to multiple opportunities to support patient driven education and research. While biopharmaceutical organizations typically work with the larger patient advocacy groups such as the American Heart Association, American Diabetes Association, and the American Cancer Society, Washer (2021) suggests both the need for and strategies to engage the smaller patient advocacy groups focused on rare diseases. Read More...